Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

The most ambitious vaccination effort in U.S. history has run headfirst into resource shortages and staffing issues caused by the raging pandemic.

Why it matters: The Trump administration's goal of vaccinating 20 million people by the end of year fell drastically short, raising concerns about how long it may be until enough people are vaccinated in the U.S. for life to return to normal.

By the numbers: 1.3% of the U.S. population has been vaccinated and 33% of the shots distributed to states have been administered, according to a Bloomberg analysis of CDC data.

  • Operation Warp Speed has distributed 13 million doses, about 7 million doses short of its goal.

The state of play: State officials have given several reasons for why vaccinations have moved at a slower-than-expected pace, per the New York Times.

  • The surge in coronavirus cases, hospitalizations and deaths have overwhelmed health care facilities, hindering their ability to deliver vaccines.
  • Many states have reserved vaccine doses for nursing homes and long-term care facilities, slowing distribution.
  • The holidays also led to reduced hours and limited staffing in clinics.

Yes, but: NIAID director Anthony Fauci said Sunday on ABC's "This Week" that he has seen "some little glimmer of hope" after 1.5 million doses were administered in the previous 72 hours, a marked increase in the vaccination rate.

What they're saying: On Friday, President Trump blamed states for not administering the vaccine fast enough.

  • "Some States are very slow to inoculate recipients despite successful and very large scale distribution of vaccines by the Federal Government. They will get it done!" he tweeted.

The other side: Los Angeles Mayor Eric Garcetti argued on "Face the Nation" that the Trump administration hasn't offered enough vaccine training to the medical workforce.

  • “We are at a pace right now to deliver vaccines in L.A. over five years, instead of over half a year," he said on Sunday.

Go deeper

How Tampa Bay is managing unused COVID vaccines

Illustration: Brendan Lynch/Axios

With so much anxiety surrounding how hard it is to get the coronavirus vaccine, a question has been lingering in many of our minds: What happens when people don't show up for their shots?

The big picture: A relatively small amount — 3,444 doses, or 0.1% of the 3 million vaccines the state has received — has been wasted.

Jan 29, 2021 - Health

J&J says its one-shot vaccine is 66% effective against moderate to severe COVID

Photo: Thiago Prudêncio/SOPA Images/LightRocket via Getty Images

Johnson & Johnson announced Friday that its single-shot coronavirus vaccine was 66% effective in protecting against moderate to severe COVID-19 disease in Phase 3 trials, which was comprised of nearly 44,000 participants across eight countries.

Between the lines: The vaccine was 72% effective in the U.S., but only 57% effective in South Africa, where a more contagious variant has been spreading. It prevented 85% of severe infections and 100% of hospitalizations and deaths, according to the company.

Jan 29, 2021 - World

EU grants conditional approval of AstraZeneca vaccine

Photo: Sunil Ghosh/Hindustan Times via Getty Images

The European Commission on Friday granted conditional approval of the Oxford-AstraZeneca coronavirus vaccine for people 18 years and older.

Why it matters: This is the third vaccine to receive approval from the commission, coming hours after the Emergency Medicines Agency recommended its authorization.